FALCONE, ROSA
FALCONE, ROSA
DIPARTIMENTO DI MEDICINA INTERNA E SPECIALITA' MEDICHE (attivo dal 01/07/2010 al 31/10/2019)
133P ARID1A-mutated cancers: New prospectives for treatment of a subgroup of gynecological cancer
2022 Falcone, R.; Filetti, M.; Lombardi, P.; Altamura, V.; Scambia, G.; Daniele, G.
1576P Efficacy of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A network meta-analysis
2022 Filetti, M.; Lombardi, P.; Falcone, R.; Giannarelli, D.; Carcagnì, A.; Giusti, R.; Scambia, G.; Daniele, G.
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
2016 Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer
2015 Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient
2017 Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica
A rare case of palatin tonsillar metastasis from small cell lung cancer
2016 D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo
ACCESS TO EARLY PHASE CLINICAL TRIALS AT THE TIME OF THE COVID-19 PANDEMIC: AN ITALIAN SURVEY
2022 Lombardi, P.; Falcone, R.; Filetti, M.; Altamura, V.; Giusti, R.; Paroni Sterbini, F.; Pietragalla, A.; Duranti, S.; Scambia, G.; Daniele, G.
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue
2020 Verrienti, Antonella; Pecce, Valeria; Abballe, Luana; Ramundo, Valeria; Falcone, Rosa; Inanloo Nigi Jak, Farzaneh; Brunelli, Chiara; Fadda, Guido; Bosco, Daniela; Ascoli, Valeria; Carletti, Raffaella; Di Gioia, Cira; Grani, Giorgio; Sponziello, Marialuisa
Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma
2018 Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial
2016 Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study
2015 Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P.
BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response
2019 Falcone, Rosa; Conte, Federica; Fiscon, Giulia; Pecce, Valeria; Sponziello, Marialuisa; Durante, Cosimo; Farina, Lorenzo; Filetti, Sebastiano; Paci, Paola; Verrienti, Antonella
Breast cancer drug approvals issued by EMA: a review of clinical trials
2021 Duranti, S.; Fabi, A.; Filetti, M.; Falcone, R.; Lombardi, P.; Daniele, G.; Franceschini, G.; Carbognin, L.; Palazzo, A.; Garganese, G.; Paris, I.; Scambia, G.; Pietragalla, A.
cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer?
2013 Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo
Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies
2020 Falcone, Rosa; Grani, Giorgio; Ramundo, Valeria; Melcarne, Rossella; Giacomelli, Laura; Filetti, Sebastiano; Durante, Cosimo
Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments
2019 Grani, G.; Tumino, D.; Ramundo, V.; Ciotti, L.; Lomonaco, C.; Armillotta, Michele; Falcone, R.; Lucia, P.; Maranghi, M.; Filetti, S.; Durante, C.
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial
2020 Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo
Connectivity significance for disease gene prioritization in an expanding universe
2020 Petti, Manuela; Bizzarri, Daniele; Verrienti, Antonella; Falcone, Rosa; Farina, Lorenzo
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer
2015 Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma
2020 Falcone, R.; Sponziello, M.; Carletti, R.; Di Gioia, C.; Nardi, F.; Mio, C.; Pecce, V.; Abballe, L.; Grani, G.; Ramundo, V.; Damante, G.; Durante, C.; Filetti, M.; Roberto, M.; Marchetti, P.; Verrienti, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 133P ARID1A-mutated cancers: New prospectives for treatment of a subgroup of gynecological cancer | 2022 | Falcone, R.; Filetti, M.; Lombardi, P.; Altamura, V.; Scambia, G.; Daniele, G. | |
| 1576P Efficacy of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A network meta-analysis | 2022 | Filetti, M.; Lombardi, P.; Falcone, R.; Giannarelli, D.; Carcagnì, A.; Giusti, R.; Scambia, G.; Daniele, G. | |
| 5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX | 2016 | Onesti, CONCETTA ELISA; Botticelli, Andrea; LA TORRE, Marco; Borro, Marina; Gentile, Giovanna; Romiti, Adriana; Lionetto, Luana; Petremolo, Antonella; Occhipinti, Mario; Roberto, Michela; Falcone, Rosa; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer | 2015 | Roberto, Michela; Romiti, Adriana; Onesti, CONCETTA ELISA; D'Antonio, Chiara; Milano, Annalisa; Falcone, Rosa; Barucca, Viola; Palombi, Lucia; Righini, Riccardo; Marchetti, Paolo | |
| A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient | 2017 | Botticelli, Andrea; Onesti, CONCETTA ELISA; Strigari, Lidia; Occhipinti, Mario; DI PIETRO, FRANCESCA ROMANA; Cerbelli, Bruna; Petremolo, Antonella; Anselmi, Elisabetta; Macrini, Serena; Roberto, Michela; Falcone, Rosa; Lionetto, Luana; Borro, Marina; Milano, Annalisa; Gentile, Giovanna; Simmaco, Maurizio; Marchetti, Paolo; Mazzuca, Federica | |
| A rare case of palatin tonsillar metastasis from small cell lung cancer | 2016 | D'Antonio, Chiara; Lombardini, Alberto; Onesti, CONCETTA ELISA; Falcone, Rosa; Romiti, Adriana; Lombardi, Marianna; Lauro, Salvatore; Marchetti, Paolo | |
| ACCESS TO EARLY PHASE CLINICAL TRIALS AT THE TIME OF THE COVID-19 PANDEMIC: AN ITALIAN SURVEY | 2022 | Lombardi, P.; Falcone, R.; Filetti, M.; Altamura, V.; Giusti, R.; Paroni Sterbini, F.; Pietragalla, A.; Duranti, S.; Scambia, G.; Daniele, G. | |
| Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue | 2020 | Verrienti, Antonella; Pecce, Valeria; Abballe, Luana; Ramundo, Valeria; Falcone, Rosa; Inanloo Nigi Jak, Farzaneh; Brunelli, Chiara; Fadda, Guido; Bosco, Daniela; Ascoli, Valeria; Carletti, Raffaella; Di Gioia, Cira; Grani, Giorgio; Sponziello, Marialuisa | |
| Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma | 2018 | Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo | |
| Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial | 2016 | Marchetti, Paolo; Milano, Annalisa; D'Antonio, Chiara; Romiti, Adriana; Falcone, Rosa; Roberto, Michela; Fais, Stefano | |
| Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study | 2015 | Milano, Annalisa; D'Antonio, Chiara; Roberto, Michela; Falcone, Rosa; DI PIETRO, FRANCESCA ROMANA; Durante, Valeria; Romiti, Adriana; Marchetti, P. | |
| BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response | 2019 | Falcone, Rosa; Conte, Federica; Fiscon, Giulia; Pecce, Valeria; Sponziello, Marialuisa; Durante, Cosimo; Farina, Lorenzo; Filetti, Sebastiano; Paci, Paola; Verrienti, Antonella | |
| Breast cancer drug approvals issued by EMA: a review of clinical trials | 2021 | Duranti, S.; Fabi, A.; Filetti, M.; Falcone, R.; Lombardi, P.; Daniele, G.; Franceschini, G.; Carbognin, L.; Palazzo, A.; Garganese, G.; Paris, I.; Scambia, G.; Pietragalla, A. | |
| cAn cArdio-vAsculAr toxicity And bmi evAluAtions predict outcomes in pAtients treAted with chemotherApy plus bevAcizumAb for metAstAtic colorectAl cAncer? | 2013 | Milano, Annalisa; D'Antonio, Chiara; Lombardini, Alberto; Durante, Valeria; Romiti, Adriana; Sarcina, Ida; Falcone, Rosa; Roberto, Michela; Marchetti, Paolo | |
| Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies | 2020 | Falcone, Rosa; Grani, Giorgio; Ramundo, Valeria; Melcarne, Rossella; Giacomelli, Laura; Filetti, Sebastiano; Durante, Cosimo | |
| Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments | 2019 | Grani, G.; Tumino, D.; Ramundo, V.; Ciotti, L.; Lomonaco, C.; Armillotta, Michele; Falcone, R.; Lucia, P.; Maranghi, M.; Filetti, S.; Durante, C. | |
| Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial | 2020 | Roberto, Michela; Romiti, Adriana; Mazzuca, Federica; Milano, Annalisa; D'Antonio, Chiara; Luana, Lionetto; Falcone, Rosa; Strigari, Lidia; Simmaco, Maurizio; Fais, Stefano; Marchetti, Paolo | |
| Connectivity significance for disease gene prioritization in an expanding universe | 2020 | Petti, Manuela; Bizzarri, Daniele; Verrienti, Antonella; Falcone, Rosa; Farina, Lorenzo | |
| Continuous, low-dose capecitabine for patients with recurrent colorectal cancer | 2015 | Romiti, Adriana; Onesti, Concetta Elisa; Roberto, Michela; Barucca, Viola; Tomao, Silverio; D’Antonio, Chiara; Durante, Valeria; Milano, Annalisa; Falcone, Rosa; Di Rocco, Roberta; Righini, Riccardo; Marchetti, Paolo | |
| Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma | 2020 | Falcone, R.; Sponziello, M.; Carletti, R.; Di Gioia, C.; Nardi, F.; Mio, C.; Pecce, V.; Abballe, L.; Grani, G.; Ramundo, V.; Damante, G.; Durante, C.; Filetti, M.; Roberto, M.; Marchetti, P.; Verrienti, A. |